Valbiotis SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 5.24 million compared to EUR 1.51 million a year ago. Net loss was EUR 1.93 million compared to EUR 5.1 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.89 EUR | -1.27% | -3.23% | -22.20% |
Apr. 26 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.20% | 66.57M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Half Year Ended June 30, 2023